Opal is the first person worldwide to receive this specific treatment at such a young age.
Casgevy is designed to work by editing the faulty gene in a patient’s bone marrow stem cells so that the body produces...
The miR-22 treatment also reduced liver inflammation and produced better survival outcomes with no observable toxicity...
